Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MAXIMUS, INC.MMS · Entity 4224 | General Mgr - Health & Human | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MAXIMUS, INC.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 21,688.577 |
Reported balance
After 2026-09-30 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-30 · Tax withholding · Disposed 3,944.553 · Balance 21,688.577 F1: These shares were surrendered to satisfy the withholding tax due in connection with the vesting of restricted stock units ("RSUs"). F2: Includes 240.271 dividend equivalents accrued on unvested RSUs since the reporting person's last Form 4 filing. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were surrendered to satisfy the withholding tax due in connection with the vesting of restricted stock units ("RSUs").
F2: Includes 240.271 dividend equivalents accrued on unvested RSUs since the reporting person's last Form 4 filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:55 UTC | MAXIMUS, INC. MMS · Entity 4224 | Tax withholdingCommon Stock | 3,944.553 | $53.19 | $209,810.77 |
DisclosureSEC source: 0001193125-26-412545 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,688.577 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the vesting of restricted stock units ("RSUs"). F2 · balance_after: Includes 240.271 dividend equivalents accrued on unvested RSUs since the reporting person's last Form 4 filing. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 01:49 UTC | MAXIMUS, INC. MMS · Entity 4224 | Tax withholdingCommon Stock | 3,831.38 | $86.51 | $331,452.68 |
DisclosureSEC source: 0001193125-25-307245 · ownership.xml · nonDerivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,392.859 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the PSUs. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 01:49 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock | 7,647.465 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-307245 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,224.239 F1 · shares: These shares were received upon the release of performance stock units ("PSUs") granted on November 25, 2022. The reported amount includes 236.401 shares representing the dividend equivalent rights accrued on the PSUs. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 01:35 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock | 27.639 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-305680 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,576.774 F1 · shares: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of Maximus common stock. Read SEC document |
| November 24, 2025 Filed Nov 25, 2025 21:51 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock | 7,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-297531 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,549.135 F1 · shares: Represents a grant of restricted stock units ("RSUs"), which vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2026, 09/30/2027, and 09/30/2028. Each RSU represents a contingent right to receive one share of common stock. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:32 UTC | MAXIMUS, INC. MMS · Entity 4224 | Tax withholdingCommon Stock | 3,622.925 | $91.37 | $331,026.66 |
DisclosureSEC source: 0001193125-25-228439 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,140.135 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the vesting of restricted stock units ("RSUs"). F2 · balance_after: The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes 11,628.365 RSUs and associated accrued dividend equivalent rights with varying distribution schedules previously reported in Table II. Read SEC document |
| August 31, 2025 Filed Sep 4, 2025 01:15 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 129.906 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-112946 · ownership.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,201.195 Underlying: Common Stock · 129.906 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| May 31, 2025 Filed Jun 4, 2025 00:49 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 156.865 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081300 · ownership.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,071.289 Underlying: Common Stock · 156.865 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 22:18 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 173.653 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-032452 · ownership.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,914.424 Underlying: Common Stock · 173.653 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:05 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 14,500 | $68.14 | $988,030.00 |
DisclosureSEC source: 0000950170-25-024259 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,511.77 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.06 to $68.21, inclusive. The reporting person will provide full information regarding the number of shares sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 02:04 UTC | MAXIMUS, INC. MMS · Entity 4224 | Tax withholdingCommon Stock | 2,592 | $74.16 | $192,222.72 |
DisclosureSEC source: 0000950170-24-133478 · ownership.xml · nonDerivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,011.771 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| December 02, 2024 Filed Dec 5, 2024 02:04 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock | 5,172 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133478 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,603.771 F1 · shares: These shares were received upon the release of performance stock units granted on November 22, 2021. Read SEC document |
| November 29, 2024 Filed Dec 4, 2024 00:34 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 92.463 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-133003 · ownership.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,054.01 Underlying: Common Stock · 92.463 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 25, 2024 Filed Nov 27, 2024 22:06 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantRestricted Stock Units · Derivative | 8,168 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-131604 · ownership.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,168 Underlying: Common Stock · 8,168 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: RSUs vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2025, 09/30/2026, and 09/30/2027. F2 · derivative.expiration_date: RSUs vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2025, 09/30/2026, and 09/30/2027. F3 · balance_after: Reporting person also holds RSUs with respect to an additional 6,871.801 shares of common stock with varying vesting schedules. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:12 UTC | MAXIMUS, INC. MMS · Entity 4224 | Tax withholdingCommon Stock | 4,924 | $93.16 | $458,719.84 |
DisclosureSEC source: 0000950170-24-111648 · ownership.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,429.456 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the vesting of restricted stock units. Read SEC document |
| August 30, 2024 Filed Sep 3, 2024 23:20 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 105.661 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000085 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,600.018 Underlying: Common Stock · 105.661 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 19:51 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 112.827 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000063 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,494.36 Underlying: Common Stock · 112.827 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 17:06 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 115.704 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-24-000025 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,381.53 Underlying: Common Stock · 115.704 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 19:35 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 10,043 | $85.57 | $859,359.42 |
DisclosureSEC source: 0001032220-23-000118 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,001.935 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:40 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 32.26 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000106 · primary_doc.xml · derivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,010.02 Underlying: Common Stock · 32.26 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 23:40 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 12 | $83.49 | $1,001.88 |
DisclosureSEC source: 0001032220-23-000106 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,717.3 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 20, 2023 Filed Nov 21, 2023 21:55 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantRestricted Stock Units · Derivative | 7,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000099 · primary_doc.xml · derivative · entry 3 Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,331 Underlying: Common Stock · 7,331 shares Expires not disclosed F3 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F4 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: A 3-year ratable vest that occurs on 09/30/2024, 09/30/2025, and 09/30/2026 F5 · balance_after: Reporting person also holds restricted stock units with respect to an additional 8,977.76 shares of common stock with varying vesting schedules. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:55 UTC | MAXIMUS, INC. MMS · Entity 4224 | Tax withholdingCommon Stock | 2,681 | $82.31 | $220,673.11 |
DisclosureSEC source: 0001032220-23-000099 · primary_doc.xml · nonDerivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,707.752 F2 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the release of the performance stock unit. Read SEC document |
| November 17, 2023 Filed Nov 21, 2023 21:55 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock | 5,349.325 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000099 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Manager - Health & Hum 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,388.752 F1 · shares: These shares were received upon the release of performance stock units granted on November 23, 2020, including 2,326.38 performance stock units which were previously reported on a Form 4 filed on November 22, 2021. Read SEC document |
| September 29, 2023 Filed Oct 3, 2023 18:21 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 7,073 | $74.68 | $528,211.64 |
DisclosureSEC source: 0001032220-23-000089 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,083 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 8977.76 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 13:46 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 140.69 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000071 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,751.09 Underlying: Common Stock · 140.69 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:10 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 139.97 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000047 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,610.39 Underlying: Common Stock · 139.97 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 22:32 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 137.36 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-23-000021 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,470.43 Underlying: Common Stock · 137.36 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 22:13 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 9,550 | $82.74 | $790,167.00 |
DisclosureSEC source: 0001032220-23-000007 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,044 F1 · price: The weighted average sales price for prices ranging from $82.69 to $82.88. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| November 30, 2022 Filed Dec 2, 2022 17:02 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 123.477 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-22-000095 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,125.2 Underlying: Common Stock · 123.477 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock. Read SEC document |
| November 25, 2022 Filed Nov 29, 2022 17:54 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock · Derivative | 5,666 | $0.00 Strike: $70.15 | $0.00 |
DisclosureSEC source: 0001032220-22-000083 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · General Mgr - Health & Human 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,666 Underlying: Common Stock · 5,666 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: Shares Vest Date 1889 09/30/2023 1889 09/30/2024 1888 09/30/2025 Expiration date not applicable to RSUs F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: Shares Vest Date 1889 09/30/2023 1889 09/30/2024 1888 09/30/2025 Expiration date not applicable to RSUs F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 17,119.249 shares of common stock with varying vesting schedules. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 18:45 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 5,783 | $57.87 | $334,662.21 |
DisclosureSEC source: 0001032220-22-000069 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,594.3 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 17119.25 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| August 31, 2022 Filed Sep 1, 2022 22:51 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 213.337 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-22-000061 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,378.245 Underlying: Common Stock · 213.337 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with RSUs to which they relate and on certain performance share units ("PSUs") where the performance criteria of such PSUs have been met. Each dividend equivalent right is the economic equivalent of one share of Maximus Common stock Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 18:52 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 198.34 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-22-000039 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,164.91 Underlying: Common Stock · 198.34 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:23 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 162.63 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-22-000005 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,966.57 Underlying: Common Stock · 162.63 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| November 30, 2021 Filed Dec 1, 2021 22:21 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 124.103 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-21-000131 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,565.426 Underlying: Common Stock · 124.103 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| November 22, 2021 Filed Nov 22, 2021 20:28 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock · Derivative | 5,535 | $0.00 Strike: $81.30 | $0.00 |
DisclosureSEC source: 0001032220-21-000120 · primary_doc.xml · derivative · entry 3 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,535 Underlying: Common Stock · 5,535 shares Expires not disclosed F4 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: Shares Vest Date 1845 09/30/2022 1845 09/30/2023 1845 09/30/2024 Expiration date not applicable to RSUs F5 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: Shares Vest Date 1845 09/30/2022 1845 09/30/2023 1845 09/30/2024 Expiration date not applicable to RSUs Read SEC document |
| November 22, 2021 Filed Dec 1, 2021 21:48 UTC Amendment | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock · Derivative | 5,535 | $0.00 Strike: $81.30 | $0.00 |
DisclosureSEC source: 0001032220-21-000130 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,535 Underlying: Common Stock · 5,535 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period at the election of individual, as permitted by the terms of the award: Shares Vest Date 1845 09/30/2022 1845 09/30/2023 1845 09/30/2024 Expiration date not applicable to RSUs F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period at the election of individual, as permitted by the terms of the award: Shares Vest Date 1845 09/30/2022 1845 09/30/2023 1845 09/30/2024 Expiration date not applicable to RSUs F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 33,441 shares of common stock with varying vesting schedules. Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 20:28 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 9,681 | $81.32 | $787,258.92 |
DisclosureSEC source: 0001032220-21-000120 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000.78 F6 · price: The weighted average sales price for prices ranging from $81.28 to $81.48. The reporting person will provide full information regarding the number of shares purchased or sold at each separate price upon request by the Commission staff, the issuer, or a security holder of the issuer. Read SEC document |
| November 18, 2021 Filed Nov 22, 2021 20:28 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock · Derivative | 2,326.38 | $0.00 Strike: $72.31 | $0.00 |
DisclosureSEC source: 0001032220-21-000120 · primary_doc.xml · derivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,326.38 Underlying: Common Stock · 2,326.38 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · shares: The shares were received for no consideration upon the satisfaction of performance criteria for the first tranche of the performance-vested restricted stock units granted on November 23, 2020 and remain subject to vesting based on continued employment through September 30, 2023. F3 · derivative.expiration_date: Expiration date not applicable to Performance RSUs Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 21:28 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 8,116 | $83.20 | $675,251.20 |
DisclosureSEC source: 0001032220-21-000114 · primary_doc.xml · nonDerivative · entry 2 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,681.78 F1 · shares: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 26,460.171 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 16:20 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 161.003 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-21-000096 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,238.999 Underlying: Common Stock · 161.003 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| May 28, 2021 Filed Jun 1, 2021 22:15 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 150.854 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-21-000061 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,077.996 Underlying: Common Stock · 150.854 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 00:57 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 171.403 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-21-000015 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,927.142 Underlying: Common Stock · 171.403 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| December 10, 2020 Filed Oct 4, 2021 21:28 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 8,672 | $70.51 | $611,462.72 |
DisclosureSEC source: 0001032220-21-000114 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 17:55 UTC Amendment | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 139.54 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-20-000118 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,841.739 Underlying: Common Stock · 139.54 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| November 30, 2020 Filed Dec 1, 2020 16:50 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantDividend Equivalent Rights · Derivative | 139.54 | $0.00 | $0.00 |
DisclosureSEC source: 0001032220-20-000113 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,926.739 Underlying: Common Stock · 139.54 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously-awarded restricted stock units ("RSU") which vest proportionately with the RSUs to which they relate. Each dividend equivalent right is the economic equivalent of one share of MAXIMUS common stock. Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 18:53 UTC | MAXIMUS, INC. MMS · Entity 4224 | GrantCommon Stock · Derivative | 6,915 | $0.00 Strike: $72.31 | $0.00 |
DisclosureSEC source: 0001032220-20-000111 · primary_doc.xml · derivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,915 Underlying: Common Stock · 6,915 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: Shares Vest Date 2305 09/30/2021 2305 09/30/2022 2305 09/30/2023 Expiration date not applicable to RSUs F2 · derivative.expiration_date: Restricted Stock Units vest based upon the following schedule, subject to deferred vesting for a longer period of the election of the individual, as permitted by the terms of the award: Shares Vest Date 2305 09/30/2021 2305 09/30/2022 2305 09/30/2023 Expiration date not applicable to RSUs F3 · balance_after: Reporting person also holds restricted stock units with respect to an additional 35,787 shares of common stock with varying vesting schedules. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 21:33 UTC | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 8,852 | $68.41 | $605,565.32 |
DisclosureSEC source: 0001032220-20-000094 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,166.1 F1 · security: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 35,787.199 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
| September 30, 2020 Filed Oct 19, 2020 17:48 UTC Amendment | MAXIMUS, INC. MMS · Entity 4224 | SaleCommon Stock | 8,852 | $68.41 | $605,565.32 |
DisclosureSEC source: 0001032220-20-000097 · primary_doc.xml · nonDerivative · entry 1 Baylinson Ilene R. · CIK 0001791080 · Group General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,672.1 F1 · security: These shares were surrendered to satisfy the withholding tax due in connection with the recent vesting of restricted stock units. F2 · balance_after: In addition, the reporting person holds 35,787.199 shares that are restricted and subject to future vesting pursuant to the terms of a grant of restricted stock previously made by the issuer to the reporting person. The reporting person does not have voting or dispositive power over these shares of restricted stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.